Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

KANJINTI vs LUTATHERA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Possible drug interaction. KANJINTI and LUTATHERA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

kanjintilutathera

Rating

72/100
72/100

Pharmacy pays

—
—

Type

RX
RX

Active ingredient

TRASTUZUMAB-ANNS
LUTETIUM LU 177 DOTATATE

Manufacturer

Amgen Inc
Aaa USA Inc

Dosage forms

Injectable
Injectable

Drug class

—
—

Boxed warning

Boxed warning
None

Treats

Breast Neoplasms, Gastrointestinal Neoplasms
Gastrointestinal Neoplasms, Pancreatic Neoplasms, Neuroendocrine Tumors

Frequently asked questions

Which is better-rated, Kanjinti or Lutathera?

Kanjinti and Lutathera are tied at 3.6 out of 5 by our independent rating.

What is the difference between Kanjinti and Lutathera?

Kanjinti contains Trastuzumab-Anns, while Lutathera contains Lutetium Lu 177 Dotatate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.